Market Size (2016)
2016
$8.91B
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$8.91B
Projected (2025)
2025
$16.29B
CAGR (2016–2025)
6.9%
6.9%Key Players
109+
This report covers Metabolomics Services Market with forecasts from 2016 to 2025. 109 key companies are profiled.
The Metabolomics Services Market market is projected to grow at a CAGR of 6.9% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Metabolomics Services Market from 2016 to 2025. Covers Asia Pacific, Americas, Europe, Middle East and Africa.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2025)
InsightAmericas leads with $6.04B by 2025, while Asia Pacific is projected to grow fastest at a 7.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $2.44B | $3.33B | $4.55B | 7.2% | 28% |
| Americas | $3.28B | $4.44B | $6.04B | 7.0% | 37% |
| Europe | $2.93B | $3.96B | $5.37B | 6.9% | 33% |
| Middle East and Africa | $259.30M | $292.60M | $334.20M | 2.9% | 2% |
| Total | $8.91B | $12.02B | $16.29B | 6.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$16.29B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Chromatography | $7.86B | 6.9% | 89% |
| Metabolomics Bioinformatics Services | $4.38B | 6.9% | 89% |
| Mass Spectrometry | $3.51B | 6.9% | 88% |
| Others | $541.50M | 6.9% | 53% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Metabolomics Services Market covering market dynamics, competitive landscape, and strategic outlook.
The Metabolomics Services Market market is projected to reach $16.29B by 2025, growing at 6.9% CAGR. The Chromatography segment holds the largest share.
The Metabolomics Services Market market encompasses 4 key regions and 4 market segments, with the study period spanning 2016 to 2025. The market demonstrates a 6.9% compound annual growth rate, reflecting strong underlying demand fundamentals.
Among the identified segments, Chromatography leads with $7.86B by 2025, followed by Metabolomics Bioinformatics Services at $4.38B. These segments collectively account for the largest share of total market revenue.
This report profiles 109 key companies operating in the Metabolomics Services Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Waters, Agilent Technologies Inc, Bruker, TMIC, Thermo Fisher Scientific Inc. , and 104 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Metabolomics Services Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Human Metabolome Technologies America Inc
Company Headquarters: Japan Founded: 2003 Workforce: ~50 Company Working: Human Metabolome Technologies America Inc. is a biotechnology company in capillary electrophoresis-mass spectrometry (CE-MS)-based metabolome analysis. The company operates through two segments— metabolome analysis and biomarker. The metabolome analysis segment provides analysis services used to analyze and measure metabolomics samples. The biomarker segment involved in the exploration of biomarkers, and the R&D of in vitro diagnostic drugs and equipment. The pharmaceutical, biotech, and food industry are the key customers of the company and use these products for drug discovery and diagnosis purpose. Geographically the company is located in the Americas, Europe, and Japan.
CREATIVE PROTEOMICS
Company Headquarters: New York, US Founded: 2004 Workforce: ~200 Company Working: Creative Proteomics, an integrated biotech contract research organization (CRO), is involved in providing a full range of drug development services which includes metabolomics, glycomics, proteomics, and bioinformatics analysis services used for research in the biotechnology, pharmaceutical, nutrition, and agriculture industries, and in some cases used by academic and government organizations. The company specializes in protein identification, protein quantification, metabolomics service, protein gel, and imaging analysis, protein post-translational modification analysis, and lipidomics service.
Biocrates Life Sciences AG
Company Headquarters: Austria Founded: 2003 Workforce: ~50 Company Working: Biocrates Life Sciences AG (Biocrates) is a global solution provider for metabolomics services. In addition to metabolomics services, the company is engaged in developing clinical biomarker assays and quality control assays to advance clinical study outcomes. The product offered by the company such as Biocrates biomarkers focuses on diagnostic of diabetes, early diagnosis of pancreatic cancer (PDAC), congestive heart failure (CHF), kidney disease, sepsis, stroke, and various types of cancer such as ovarian and breast cancer.
TMIC
Company Headquarters: Alberta, Canada Founded: 2011 Workforce: ~51-200 Company Working: TMIC (The Metabolomics Innovation Centre) is a nationally-funded core facility. It has an exceptional blend of infrastructure and employees to accomplish a wide range of cutting-edge metabolomic studies for clinical trials research, bioproducts studies, nutrient profiling biomedical studies, and environmental testing. It offers a diverse set of technologies for targeted, quantitative, and untargeted metabolomics using nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), and metabolite imaging. TMIC is widely spread, fee-for-service, university-based core facility providing quantitative metabolomics services for Canada’s public and private research sectors.
Bruker
Company Headquarters: Massachusetts, US Founded: 1960 Workforce: ~6500 Company Working: Bruker is specialized as the developer, manufacturer, and distributor of scientific instruments, analytical, and diagnostic solutions products. Bruker operates through two segments, namely Bruker Scientific Instruments and Bruker Energy & Supercon Technologies. It has technical and manufacturing centers present across Europe and North America. The company is making significant investments in R&D, to introduce innovative manufacturing processes.
Waters
Company Headquarters: Massachusetts, US Founded: 1958 Workforce: ~7,200 Company Working: Waters is involved in manufacturing, development, and marketing of mass spectrometry (MS) instruments and components. Waters’ products are used by pharmaceutical, health science, food and environmental testing, chemical, industrial, contract laboratory, academic, and government organizations working in research & development (R&D), quality assurance, and other laboratory applications. Its chromatography and mass spectrometry instruments, software, and chemistry consumables are used in a wide range of industries to measure the chemical, physical, and biological composition of materials.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Metabolomics Services Market